Top risks for life sciences sector revealed – new WTW report

An article from Insurance Business mag.

Global broker WTW has released a report on the 2023 risk outlook for the health and life sciences sector.

“The life science industry is in a period of transformation, from new clinical trial models and evolving regulatory approvals to digitalisation and automation of processes,” WTW said. “Though hugely promising, these rapid advances can be difficult to adapt to in the short term. They also raise ethical and legal questions, around issues such as data privacy and consent and health equity.”

Read more.